Ann Surg Oncol

1. HOPPING E, Gauci E, Brown K, Bhimani N, et al
   Circulating Extracellular Vesicle Biomarkers as Diagnostic and Prognostic Biomarkers of Liver Metastasis in Colorectal Cancer: A Systematic Review.
   Ann Surg Oncol. 2026 Jan 22. doi: 10.1245/s10434-025-18934.
   

   >> Share

   
   
2. SASSUN R, Larson DW, Sileo A, Sabella G, et al
   Do Tumor Deposits Demand More? Association of Chemotherapy Regimen Intensity with Survival Outcomes in N1 Colon Cancer Patients with Tumor Deposits.
   Ann Surg Oncol. 2026 Jan 21. doi: 10.1245/s10434-026-19123.
   

   >> Share

   
   
3. MOAVEN O
   Does Prophylactic Intraperitoneal Chemotherapy Provide Any Clinical Benefit After Curative Colorectal Cancer Resection?
   Ann Surg Oncol. 2026 Jan 20. doi: 10.1245/s10434-026-19095.
   

   >> Share

   
   
4. ZHOU Y, Zuo Z, Zhao J, Liu L, et al
   ASO Author Reflections: Time-to-Event Machine Learning for Prognostication of Locally Advanced Colorectal Cancer: Insights into Current Progress and Future Directions.
   Ann Surg Oncol. 2026 Jan 18. doi: 10.1245/s10434-025-18949.
   

   >> Share

   
   

   
   BMC Cancer

5. LIU D, Fan Z, Zhang T, Li X, et al
   Rs12516 A allele elevates the risk of colorectal cancer via functional CeRNA network of BDNF-AS, miR-4704-5p and BRCA1.
   BMC Cancer. 2026 Jan 19. doi: 10.1186/s12885-025-14692.
   

   >> Share

   
   

   
   Br J Cancer

6. BOWDEN SJ, Ellis LB, Cuming T, Brogden D, et al
   Multizonal intraepithelial neoplasia of the lower genital tract and anus in women: terminology for defining the disease, an introduction by the British Society for Colposcopy and Cervical Pathology (BSCCP), International Anal Neoplasia Society (IANS),
   Br J Cancer. 2026;134:177-184.
   

   >> Share

   
   

   
   Cancer Lett

7. FANG X, Huang H, Zhao Z, Yang L, et al
   KLF7 as a biomarker for the pre-metastatic state promotes colorectal cancer liver metastasis via TGFbeta autocrine signaling.
   Cancer Lett. 2026;639:218123.
   

   >> Share

   
   

   
   Cancer Res

8. KREGER BT, Liang Y, Reilly NM, Spears ME, et al
   CFT1946 Is an Orally Available Brain-Penetrant BRAFV600-Mutant Degrader That Overcomes BRAF Inhibitor Resistance.
   Cancer Res. 2026;86:438-452.
   

   >> Share

   
   

   
   Clin Cancer Res

9. SALEM ME, Puccini A, Mauer E, Andre T, et al
   Impact of RAS/BRAFV600E Mutations on the Tumor Immune Microenvironment in Mismatch Repair-Deficient/Microsatellite Instability Colorectal Cancers.
   Clin Cancer Res. 2026;32:417-427.
   

   >> Share

   
   

   
   Clin Res Hepatol Gastroenterol

10. LI W, Zhou S, Zhong Q, Huang L, et al
    Creating and validating an anastomotic leakage risk prediction model after laparoscopic low anterior resection for rectal cancer.
    Clin Res Hepatol Gastroenterol. 2026;50:102745.
    

    >> Share

    
    

    
    Eur J Cancer

11. MAERTEN P, Defraene G, Wolthuis A, Schraepen C, et al
    Long-term recurrence patterns in rectal cancer after neoadjuvant therapy: 25-years of real-world data.
    Eur J Cancer. 2026;234:116199.
    

    >> Share

    
    
12. ZHANG X, Zhou J, Geng J, Li Y, et al
    Feasibility of ctDNA-guided precision neoadjuvant therapy in locally advanced rectal cancer: Insights from the ongoing CINTS-R trial.
    Eur J Cancer. 2026;234:116193.
    

    >> Share

    
    

    
    Gastroenterology

13. DOMINITZ JA, Robertson DJ
    Is a Goldilocks Solution for Colorectal Cancer Screening Just a Fairy Tale? Overdiagnosis Versus Later Diagnosis of Premalignant Lesions.
    Gastroenterology. 2026 Jan 21:S0016-5085(26)00004.
    

    >> Share

    
    
14. TSAI YY, Thomas CE, Law PJ, Chen Z, et al
    HLA Heterozygosity Influences Colorectal Cancer Risk and Survival Outcome.
    Gastroenterology. 2026 Jan 20:S0016-5085(25)06150.
    

    >> Share

    
    

    
    Gastrointest Endosc

15. MEDAWAR E, Taghiakbari M, Djinbachian R, Shahidi N, et al
    Safety and efficacy of margin and base ablation after endoscopic mucosal resection of large nonpedunculated colorectal polyps: a prospective multicenter study.
    Gastrointest Endosc. 2026;103:284-292.
    

    >> Share

    
    
16. WANG L, Du L, Liu ZQ, Luo SB, et al
    Feasibility and safety of endoscopic submucosal dissection for the anal canal lesions.
    Gastrointest Endosc. 2026;103:312-321.
    

    >> Share

    
    
17. UEDA T, Yoshii S, Kanesaka T, Tani Y, et al
    Endoscopic submucosal resection using a ligation band without injection for rectal neuroendocrine tumors (with video).
    Gastrointest Endosc. 2026;103:338-342.
    

    >> Share

    
    

    
    Int J Colorectal Dis

18. ARROYO A, Lopez-de-Lerma C, Perea M, Sanchez-Romero A, et al
    Functional, oncologic and clinical outcomes of robotic rectal resection using the Hugo RAS system versus laparoscopic surgery: A comparative cohort study.
    Int J Colorectal Dis. 2026;41:40.
    

    >> Share

    
    
19. YU ZH, Jong BK, Hsu YJ, You JF, et al
    Short-term outcomes of minimally invasive surgery in older colorectal cancer patients in the era of enhanced recovery after surgery: is a "one-size-fits-all" strategy sufficient?
    Int J Colorectal Dis. 2026;41:37.
    

    >> Share

    
    

    
    J Clin Oncol

20. KANEMITSU Y, Shimizu Y, Mizusawa J, Inaba Y, et al
    Randomized Phase II/III Trial Comparing Hepatectomy, Followed by mFOLFOX6 With Hepatectomy Alone for Liver Metastasis From Colorectal Cancer: Long-Term Results of JCOG0603.
    J Clin Oncol. 2026 Jan 21:JCO2501231. doi: 10.1200/JCO-25-01231.
    

    >> Share

    
    
21. GERMANI MM, Borelli B, Cremolini C
    Reply to: From Thresholds to Tumor Sidedness: Reframing Human Epidermal Growth Factor Receptor 2 in Colorectal Cancer.
    J Clin Oncol. 2026 Jan 20:JCO2502817. doi: 10.1200/JCO-25-02817.
    

    >> Share

    
    
22. LIANG X, Lei H
    From Thresholds to Tumor Sidedness: Reframing Human Epidermal Growth Factor Receptor 2 in Colorectal Cancer.
    J Clin Oncol. 2026 Jan 20:JCO2502335. doi: 10.1200/JCO-25-02335.
    

    >> Share

    
    

    
    J Natl Cancer Inst

23. LIEBERMAN D
    Centers for Medicare and Medicaid and colorectal cancer screening test standards: time for a change.
    J Natl Cancer Inst. 2026 Jan 16:djaf367. doi: 10.1093.
    

    >> Share

    
    

    
    Oncogene

24. WANG B, Zhang S, Guo Y, Gao W, et al
    Correction: CBX2 as a therapeutic target in colorectal cancer: insights into the altered chromatin accessibility via RUNX1-CBX2-MAP4K1 axis.
    Oncogene. 2026 Jan 21. doi: 10.1038/s41388-026-03677.
    

    >> Share

    
    

    
    Oncol Rep

25. QIU M, Lan C, Lin M, Ma H, et al
    Key immune cells in the tumor immune microenvironment of colorectal cancer: Roles and research advances (Review).
    Oncol Rep. 2026;55:52.
    

    >> Share

    
    

    
    PLoS One

26. JIANG L, Peng Z, Liu R, Chen L, et al
    A study on the effect of CBSM-based psychological intervention on self-management ability and quality of life in colorectal cancer patients from the perspective of benefit finding: A quasi-experimental study.
    PLoS One. 2026;21:e0339472.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share